112 related articles for article (PubMed ID: 30584073)
21. Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations.
Dabkowski TR; Varkhedi M; Song JJ; Gozlan EC; Blanck G
JCO Precis Oncol; 2023 Sep; 7():e2300057. PubMed ID: 38085056
[TBL] [Abstract][Full Text] [Related]
22. Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based
Suematsu M; Yagyu S; Hosoi H; Iehara T
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972781
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.
Jamin Y; Tucker ER; Poon E; Popov S; Vaughan L; Boult JK; Webber H; Hallsworth A; Baker LC; Jones C; Koh DM; Pearson AD; Chesler L; Robinson SP
Radiology; 2013 Jan; 266(1):130-40. PubMed ID: 23169794
[TBL] [Abstract][Full Text] [Related]
24. Somatic structural variation targets neurodevelopmental genes and identifies
Lopez G; Conkrite KL; Doepner M; Rathi KS; Modi A; Vaksman Z; Farra LM; Hyson E; Noureddine M; Wei JS; Smith MA; Asgharzadeh S; Seeger RC; Khan J; Auvil JG; Gerhard DS; Maris JM; Diskin SJ
Genome Res; 2020 Sep; 30(9):1228-1242. PubMed ID: 32796005
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of sequence-specific alkylating agents: pyrolle-imidazole CBI conjugates with indole linker.
Shinohara K; Bando T; Sasaki S; Sakakibara Y; Minoshima M; Sugiyama H
Cancer Sci; 2006 Mar; 97(3):219-25. PubMed ID: 16542219
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel gene signature for neuroblastoma differentiation using a Boolean implication network.
Zage PE; Huo Y; Subramonian D; Le Clorennec C; Ghosh P; Sahoo D
Genes Chromosomes Cancer; 2023 Jun; 62(6):313-331. PubMed ID: 36680522
[TBL] [Abstract][Full Text] [Related]
27. Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children.
Lin L; Wang B; Zhang X; Deng C; Zhou C; Zhu J; Wu H; He J
IUBMB Life; 2024 Apr; 76(4):200-211. PubMed ID: 38014648
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents.
Biegel JM; Dhamdhere M; Gao S; Gowda CP; Kawasawa YI; Spiegelman VS
Front Oncol; 2021; 11():608816. PubMed ID: 33796454
[TBL] [Abstract][Full Text] [Related]
29. Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.
Chesler L; Weiss WA
Semin Cancer Biol; 2011 Oct; 21(4):245-55. PubMed ID: 21958944
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of MYCN-activating mutation and amplification in a patient with neuroblastoma.
Kojima M; Touge R; Kurihara S; Saeki I; Takahashi S; Hiyama E
Pediatr Blood Cancer; 2024 May; ():e31115. PubMed ID: 38773728
[No Abstract] [Full Text] [Related]
31. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH
J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140
[TBL] [Abstract][Full Text] [Related]
32. Predicting clinical outcomes in neuroblastoma with genomic data integration.
Baali I; Acar DAE; Aderinwale TW; HafezQorani S; Kazan H
Biol Direct; 2018 Sep; 13(1):20. PubMed ID: 30621745
[TBL] [Abstract][Full Text] [Related]
33. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
Chlenski A; Park C; Dobratic M; Salwen HR; Budke B; Park JH; Miller R; Applebaum MA; Wilkinson E; Nakamura Y; Connell PP; Cohn SL
Mol Cancer Ther; 2019 Mar; 18(3):507-516. PubMed ID: 30674566
[TBL] [Abstract][Full Text] [Related]
34.
Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
[TBL] [Abstract][Full Text] [Related]
35. ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.
Zhang Q; Xiao M; Gu S; Xu Y; Liu T; Li H; Yu Y; Qin L; Zhu Y; Chen F; Wang Y; Ding C; Wu H; Ji H; Chen Z; Zu Y; Malkoski S; Li Y; Liang T; Ji J; Qin J; Xu P; Zhao B; Shen L; Lin X; Feng XH
Nat Cell Biol; 2019 Feb; 21(2):179-189. PubMed ID: 30664791
[TBL] [Abstract][Full Text] [Related]
36. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
Naranjo A; Irwin MS; Hogarty MD; Cohn SL; Park JR; London WB
JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652588
[TBL] [Abstract][Full Text] [Related]
37. Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry.
De Bernardi B; Di Cataldo A; Garaventa A; Massirio P; Viscardi E; Podda MG; Castellano A; D'Angelo P; Tirtei E; Melchionda F; Vetrella S; De Leonardis F; D'Ippolito C; Tondo A; Nonnis A; Erminio G; Gigliotti AR; Mazzocco K; Haupt R
Ital J Pediatr; 2019 Jan; 45(1):8. PubMed ID: 30634996
[TBL] [Abstract][Full Text] [Related]
38. Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy.
Meany HJ
Children (Basel); 2019 Jan; 6(1):. PubMed ID: 30626019
[TBL] [Abstract][Full Text] [Related]
39. Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15.
Chen Y; Sun C; Landoni E; Metelitsa L; Dotti G; Savoldo B
Clin Cancer Res; 2019 May; 25(9):2915-2924. PubMed ID: 30617136
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Ki-67 as prognostic factor for pediatric neuroblastoma and the possibility of molecular-targeted drugs with VEGF and PDGFR.
Watanabe S; Suzuki T; Kondo Y; Naoe A; Uga N; Yasui T; Hara F; Tsuchiya T
Minerva Pediatr (Torino); 2023 Aug; 75(4):561-566. PubMed ID: 30605998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
